首站-论文投稿智能助手
典型文献
Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity
文献摘要:
Diabetes mellitus and associated chronic hyperglycemia enhance the risk of acute ischemic stroke and lead to worsened clinical outcome and increased mortality. However, post-stroke hyperglycemia is also present in a number of non-diabetic patients after acute ischemic stroke, presumably as a stress response. The aim of this review is to summarize the main effects of hyperglycemia when associated to ischemic injury in acute stroke patients, highlighting the clinical and neurological outcomes in these conditions and after the administration of the currently approved pharmacological treatment, i.e. insulin. The disappointing results of the clinical trials on insulin (including the hypoglycemic events) demand a change of strategy based on more focused therapies. Starting from the comprehensive evaluation of the physiopathological alterations occurring in the ischemic brain during hyperglycemic conditions, the effects of various classes of glucose-lowering drugs are reviewed, such as glucose-like peptide-1 receptor agonists, DPP-4 inhibitors and sodium glucose cotransporter 2 inhibitors, in the perspective of overcoming the up-to-date limitations and of evaluating the effectiveness of new potential therapeutic strategies.
文献关键词:
作者姓名:
Federica Ferrari
作者机构:
Department of Biology and Biotechnology,Laboratory of Pharmacology and Molecular Medicine of Central Nervous System,University of Pavia,Via Ferrata,Pavia,Italy
引用格式:
[1]Federica Ferrari-.Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity)[J].中国神经再生研究(英文版),2022(02):292-299
A类:
physiopathological
B类:
Hyperglycemia,acute,ischemic,stroke,therapeutic,complexity,Diabetes,mellitus,associated,chronic,hyperglycemia,enhance,risk,lead,worsened,clinical,increased,mortality,However,post,also,present,number,diabetic,patients,after,presumably,stress,response,aim,this,summarize,main,effects,when,injury,highlighting,neurological,outcomes,these,conditions,administration,currently,approved,pharmacological,treatment,insulin,disappointing,results,trials,including,hypoglycemic,events,demand,change,strategy,more,focused,therapies,Starting,from,comprehensive,evaluation,alterations,occurring,brain,during,hyperglycemic,various,classes,glucose,lowering,drugs,are,reviewed,such,like,peptide,receptor,agonists,DPP,inhibitors,sodium,cotransporter,perspective,overcoming,up,date,limitations,evaluating,effectiveness,new,potential,strategies
AB值:
0.632777
相似文献
Efficacy and safety of a sequential treatment with clearing heat and eliminating phlegm and tonifying Qi and activating blood circulation in treating acute ischemic stroke:study protocol for a randomized controlled trial
ZHOU Ziyi;WAN Can;ZHAO Yuanqi;LIU Xiangzhe;GAO Ying;AN Hongwei;LI Lejun;ZHANG Huili;YU Xiaofei;ZHANG Xinchun;WANG Huijuan;SHI Qing;WEI Chunhua;CHEN Jie;HUANG Wenguo;CHEN Junbin;HU Mingzhe;CAI Yefeng-Department of Neurology,Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120,China;The Second Clinical College of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;the Second Clinical College of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Neurology,The First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou 450000,China;Department of Neurology,Shenyang Second Hospital of Traditional Chinese Medicine,Shenyang 110100,China;Department of Neurology and Stroke Center,Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine,Beijing 100700,China;Department of Neurology,Liuzhou Traditional Chinese Medical Hospital,Liuzhou 545001,China;Department of Neurology,Wuxi Traditional Chinese Medicine Hospital,Wuxi 214071,China;Department of Neurology,Qinhuangdao City Hospital of Traditional Chinese Medicine,Qinhuangdao 066000,China;Department of Neurology,Shanghai Shuguang Hospital,Shanghai 200120,China;Department of Neurology,the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China;Department of Neurology,Jiangmen Wuyi Hospital of Traditional Chinese Medicine,Jiangmen 529000,China;Department of Neurology,Nanshi Hospital Affiliated to Henan University,Nanyang 473065,China;Department of Neurology,Shanxi Province Hospital of Traditional Chinese Medicine,Xi'an 710003,China;Department of Neurology,Maoming Hospital of Traditional Chinese Medicine,Maoming 525000,China;Department of Neurology,the Northern Guangdong People's Hospital,Shaoguan 512025,China;Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, China
Quantitative proteomics revealed extensive microenvironmental changes after stem cell transplantation in ischemic stroke
Yao Chen;Fahuan Song;Mengjiao Tu;Shuang Wu;Xiao He;Hao Liu;Caiyun Xu;Kai Zhang;Yuankai Zhu;Rui Zhou;Chentao Jin;Ping Wang;Hong Zhang;Mei Tian-Department of Nuclear Medicine and Medical PET Center,The Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,China;Institute of Nuclear Medicine and Molecular Imaging,Zhejiang University,Hangzhou 310009,China;Key Laboratory of Medical Molecular Imaging of Zhejiang Province,Hangzhou 310009,China;Department of Radiology,Zhejiang Hospital,Hangzhou 310030,China;Department of PET Center The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310006,China;Key Laboratory for Biomedical Engineering of Ministry of Education,Zhejiang University,Hangzhou 310027,China;College of Biomedical Engineering and Instrument Science,Zhejiang University,Hangzhou 310027,China;Shanxi Medical University,Taiyuan 030001,China
Novel Caspase-1 inhibitor CZL80 improves neurological function in mice after progressive ischemic stroke within a long therapeutic time-window
Ling Pan;Wei-dong Tang;Ke Wang;Qi-feng Fang;Meng-ru Liu;Zhan-xun Wu;Yi Wang;Sun-liang Cui;Gang Hu;Ting-jun Hou;Wei-wei Hu;Zhong Chen;Xiang-nan Zhang-Institute of Pharmacology and Toxicology,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province,School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China;Department of Pharmachemistry,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Department of Pharmacology,School of Medicine and Life Sciences,Nanjing University of Chinese Medicine,Nanjing 210029,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。